The Online Investor
Daily M&A
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
Specialty Chemicals M&A image Specialty Chemicals M&A » By The Online Investor Staff, updated Tue., Apr. 30, 10:15 AM Recent mergers and acquisitions in the Specialty Chemicals M&A category.

Slide #6. SI Group Albemarle's antioxidant, ibuprofen and propofol businesses

Acquirer: SI Group
Acquiree: Albemarle's antioxidant, ibuprofen and propofol businesses (NYSE:ALB)
Details: Albemarle Corporation (NYSE: ALB), a leading manufacturer of highly-engineered specialty chemicals, announced today that it has signed a definitive agreement to sell certain assets to SI Group, a leading global developer and manufacturer of chemical intermediates, specialty resins, and solutions. Included in the transaction are Albemarle's antioxidants and FDA-regulated ibuprofen and propofol businesses and assets, with manufacturing sites in Orangeburg, South Carolina and Jinshan, China; and Albemarle's antioxidant product lines. Certain applications and technical support capabilities in Shanghai, China and Baton Rouge, Louisiana will also be included in the transaction. Terms of the transaction were not disclosed.



Open the ALB Page at The Online Investor »

Company Name:  Albemarle Corp.
Stock buyback:  ALB buyback
Website:  www.albemarle.com
Sector:  Specialty Chemicals
Number of ETFs Holding ALB:  104
Total Market Value Held by ETFs:  $2.91B
Total Market Capitalization:  $13.50B
% of Market Cap. Held by ETFs:  21.58%
 

Open the ALB Page at The Online Investor (in a new window) »

April 30, 2024    10:15 AM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree ALB Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.03 out of 4)
33rd percentile
(ranked lower than approx. 67% of all stocks covered)

Analysts' Target Price:
ALB Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Specialty Chemicals M&A - Slide 6 of 91 | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.